Trial of lurbinectedin for small cell lung cancer meets primary endpoint - Healio

Trial of lurbinectedin for small cell lung cancer meets primary endpoint  Healio

A phase 2 trial designed to evaluate the safety and efficacy of lurbinectedin for patients with relapsed small cell lung cancer met its primary endpoint of overall ...



Comments

Popular posts from this blog

Stage 4 Lung Cancer Life Expectancy

Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic ...

Free biotech stocks directory, pharma stocks, telemedicine stocks ...